Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms

Source: Sapre M, Tremblay D, Leiter A, et al. SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. Journal of the Endocrine Society, Volume 3, Issue Supplement 1, April-May 2019. DOI: 10.1210/js.2019-SAT-091

Please sign in or register for FREE

No comments yet.